Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lisa G M, Huis In 't Veld"'
Autor:
Harry Dolstra, Gosse J Adema, Nataschja I Ho, Lisa G M Huis in 't Veld, Jesper van Eck van der Sluijs, Branco M H Heuts, Maaike W G Looman, Esther D Kers-Rebel, Koen van den Dries, Joost H A Martens, Willemijn Hobo
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 8 (2023)
Background Adjuvants are key for effective vaccination against cancer and chronic infectious diseases. Saponin-based adjuvants (SBAs) are unique among adjuvants in their ability to induce robust cell-mediated immune responses in addition to antibody
Externí odkaz:
https://doaj.org/article/c01dcb8743c64477b7c1e9befc909182
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Over the last decades, vaccine development has advanced significantly in pursuing higher safety with less side effects. However, this is often accompanied by a reduction in vaccine immunogenicity and an increased dependency on adjuvants to enhance va
Externí odkaz:
https://doaj.org/article/f5e78b49a87548288b6c3f2e24b5487b
Autor:
Lisa G M, Huis In 't Veld, Nataschja I, Ho, Melisssa, Wassink, Martijn H, den Brok, Gosse J, Adema
Publikováno v:
Cellular and molecular life sciences : CMLS. 79(5)
Saponin-based adjuvants (SBAs) are promising new adjuvants that stand out as they not only enforce CD4 + T cell-mediated immunity and antibody responses, but also induce an unprecedented level of antigen cross-presentation by dendritic cells (DC) and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::409030c47f34c1a8bc9d54c91aafd0ad
https://pubmed.ncbi.nlm.nih.gov/35396971
https://pubmed.ncbi.nlm.nih.gov/35396971